JTC Team and LaVoieHealthScience (LHS), announced their partnership to host the April 2020 Virtual Investor Summit on April 22nd and 23rd from 10:00 AM – 12:00 PM ET and 1:00 PM – 3:00 PM ET on both days. The Virtual Investor Summit will feature public and private companies from multiple industries including life sciences/biotech, infrastructure and transportation. As part of the event, management teams will present a live audio webcast accompanied by a slide presentation and be available to participate in virtual Q&A sessions immediately following their presentation.
Investors, media and interested parties can access the event schedule and individual company webcast details at the event website, virtualinvestorsummit.com.
Public companies to present at the Virtual Investor Summit include:
Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZS), American Resources Corporation (NASDAQ: AREC), Ceapro Inc. (OTCQX: CRPOF; TSX-V: CZO), Cocrystal Pharma Inc. (NASDAQ: COCP), Guardion Health Sciences, Inc. (NASDAQ: GHSI), Matinas BioPharma (NYSE AMER: MTNB), Outlook Therapeutics, Inc. (NASDAQ: OTLK), TFF Pharmaceuticals Inc. (NASDAQ: TFFP), and Xenetic Biosciences Inc. (NASDAQ: XBIO).
Private companies to present include:
Celavie Biosciences & Celavet, Inc., Charge, Inc., DeMelle OncoPharma, EuMentis Therapeutics, Omega Therapeutics and SIRION Biotech.
For more information about the event, please visit the conference website at virtualinvestorsummit.com or contact info@virtualinvestorsummit.com.
